No translate

Phan Tuấn Đạt; Phạm Mạnh Hùng; Nguyễn Lân Việt

doi:10.58354/jvc.9192.2020.1243

Home

NGHIÊN CỨU LÂM SÀNG Issue: Số 91+92, 2021 BỆNH MẠCH VÀNH

No translate

Published: September 8, 2026

10.58354/jvc.9192.2020.1243

Abstract

No translate

Keywords

No translate

References

1. Thomas J Cahill, Rajesh K Kharbanda (2017). Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Mechanisms, incidence and identification of patients at risk. World J Cardiol; 9(5): 407-415.

DOI: doi.org/10.4330/wjc.v9.i5.407

2. Delewi R, Hirsch A, Tijssen JG, et al (2014). Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis. Eur Heart J; 35(15), 989-98.

3. Staat, P, et al (2005). Postconditioning the human heart. Circulation; 112(14): 2143-8.

4. Shone O. Almeida, Rhys J. Skelton, et al (2015). Arrhythmia in Stem Cell Transplantation. Card Electrophysiol Clin; 7(2): 357-370.

5. Menasché P, Alfieri O, et al (2008). The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation; 117: 1189-1200.

DOI: doi.org/10.1161/circulationaha.105.558122

6. Mills WR, Mal N, Kiedrowski MJ, et al (2007). Stem cell therapy enhances electrical via- bility in myocardial infarction. J Mol Cell Cardiol; 42: 304-14.

7. Schachinger V, et al (2006). Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J; (27), 2775-83.

DOI: doi.org/10.1016/j.ccep.2015.03.012

8. Janssens S, Dubois C, et al (2006). Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet; 367:113-121.

9. Lunde K, Solheim S, et al (2008). Anterior myocardial infarction with acute percutaneous coronary inter- vention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months’ follow-up. J Am Coll Cardiol; 51:674-676.

DOI: doi.org/10.1161/circulationaha.107.734103

10.

10. Wollert KC, Meyer GP, et al (2004). Intracoronary autologous bone- marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet; 364:141-148.

Tác giả

Phan Tuấn Đạt: Viện Tim mạch Việt Nam, Bệnh viện Bạch Mai; Phạm Mạnh Hùng: Trường Đại học Y Hà Nội; Nguyễn Lân Việt: Nguyên Hiệu trưởng Trường Đại học Y Hà Nội; Nguyên Viện trưởng Viện Tim mạch Việt Nam; Phó Chủ tịch Thường trực Hội Tim mạch học Việt Nam;